Synaptogenix, Inc.

SNPX | NASDAQ | 1 Followers
$3.71 -23.66% -$1.15
Follow
Loading...

Profile

Synaptogenix, Inc. (SYN) is a biotechnology company focused on researching and developing therapeutic approaches for neurodegenerative diseases, such as Alzheimer's disease. The company is dedicated to discovering and developing drug candidates that could impact the pathological processes associated with these diseases. Their research centers around mechanisms related to amyloid and tau proteins, which are characteristic of Alzheimer's disease. Synaptogenix aims to bring forth new approaches to treatment and slowing the progression of progressive neurodegenerative damage. Investors interested in drug development for neurodegenerative diseases and innovations in the field of neurology might see potential in Synaptogenix, Inc. (SYN) shares for progress and growth in this domain.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade